两部门：已督促雀巢完成其在中国大陆销售的特定批次产品召回工作

Core Viewpoint - The article reports on the preventive recall of specific batches of Nestlé infant formula in China due to the detection of Bacillus cereus emetic toxin, with no confirmed cases of poisoning reported so far [1] Group 1: Company Actions - The State Administration for Market Regulation (SAMR) has urged Nestlé (China) Co., Ltd. to complete the recall of specific batches of products sold in mainland China [1] - Nestlé is cooperating with regulatory authorities to ensure the safety of its infant formula products [1] Group 2: Regulatory Response - The SAMR has deployed measures to enhance the quality and safety control of infant formula, emphasizing the need for all manufacturers to conduct testing for Bacillus cereus emetic toxin [1] - Strict controls on raw material acceptance and product release are being enforced to safeguard the quality of infant formula [1]